|Videos|July 15, 2020

Who Should be Wearing Face Masks?

Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.

With the heat of the summer here and people participating in get togethers including picnics, BBQs, and family outings at the beach, everyone is seeing more people in close proximity compared to the spring. And at the same time, coronavirus 2019 (COVID-19) cases are spiking.

In the Southwest and South of the US, the cases are seeing record numbers. And in at least one state, Florida, its mortality rate has gone up. Florida saw 132 cases of COVID-19 related deaths recorded yesterday.

As the uncertainty over who and where people should be wearing face masks remains, the medical consensus is that masks help. As states, businesses, and local municipalities begin to grapple with and implement face mask requirements, there are different rules as to when they should be worn. In addition, some states have not required people to wear face masks in public.

In the first segment of a two-part interview with Contagion®, Rajiv Dhand, MD, professor and chair, Department of Medicine and associate dean of clinical affairs, University of Tennessee Graduate School of Medicine discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.

When asked about health care workers who are seeing patients outside the hospital, Dhand was in favor of them wearing face masks. “Yes, definitely," Dhand said. "They should be taking all precautions because as you know this is really a highly infectious virus and it can easily be transmitted.”


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.